Vascular Health and Risk Management (May 2021)

Risk Factor Management in Non-Metropolitan Patients with Coronary and Peripheral Artery Disease – A Protocol of a Prospective, Multi-Center, Quality Improvement Strategy

  • Zemmrich C,
  • Bramlage P,
  • Hillmeister P,
  • Sacirovic M,
  • Buschmann I

Journal volume & issue
Vol. Volume 17
pp. 267 – 272

Abstract

Read online

Claudia Zemmrich,1 Peter Bramlage,2 Philipp Hillmeister,3 Mesud Sacirovic,3 Ivo Buschmann3 1Deutsche Angiologie-CRO, Berlin, Germany; 2Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany; 3Department of Angiology, Medical University Brandenburg, Brandenburg, GermanyCorrespondence: Claudia ZemmrichDeutsche Angiologie CRO (DA-CRO), Straubinger Strasse 20, Berlin, 12683, GermanyTel +49 178 7152405Email [email protected]: Coronary artery disease (CAD) and peripheral arterial disease (PAD) account for significant morbidity and mortality in Germany and are more prevalent in rural, non-metropolitan areas. The goal of this study is to screen patients for their current atherosclerotic status, initiate treatment according to the latest scientific findings using a standardised multimodal approach and track their atherosclerotic status over one year.Methods and Analysis: This manuscript describes the study protocol of a prospective, multicentre registry of 500 sequential patients with CAD and/or PAD in rural, non-metropolitan regions of Germany. Patients, who visit the “WalkByLab” at the Brandenburg Medical School, Brandenburg, Germany, will be assessed by using our structured, multimodal risk factor management (SMART) tool to evaluate cardiovascular morbidity data, collect information on care and deliver multimodal therapy. The study’s primary objective is a cross-sectional examination of the risk profile, diagnostic and therapeutic status in this patient group. Secondary objectives include the assessment of risk factor correlations as well as changes in risk-factor profile and therapy adherence. Patients will be examined at baseline and followed up at three-monthly intervals for one year. Over this time, atherosclerotic risk factors and patient adherence to defined therapeutic strategies will be evaluated. Study completion is estimated to be December 2021. An expansion of this concept into other rural, non-metropolitan neighbouring regions is planned.Ethics and Dissemination: This registry was assessed and approved by the ethics committee of the Brandenburg State Medical Association, Brandenburg, Germany, and conducted in accordance with the Declaration of Helsinki. The study findings will be disseminated through usual academic channels including meeting presentations and peer-reviewed publications.Protocol Version: 1.0.Keywords: coronary artery disease, peripheral arterial disease, atherosclerosis, rural, risk factor, quality improvement

Keywords